+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

AI in Endoscopy Market Size, Share and Growth Outlook, 2026: Analysis By Component (Hardware Systems , Software Solutions, Operational and Maintenance Services), By Application (Gastrointestinal Endoscopy, Urological Endoscopy, Respiratory , Laparoscopic Surgery), By Modality (On-Premise , Cloud-Based ), By Core Functionality (Computer-Aided Detection (CADe), Computer-Aided Diagnosis , Real-time Quality & Workflow Support, Training and Surgical Simulation), By End-User (Hospitals and Emergency Care Units, Ambulatory Surgical Centers (ASCs), Specialized Diagnostic & Gastrointestinal Clinics) Companies, and Country Forecast, 2021 to 2034

Global AI in Endoscopy Market size is forecast to increase from $599.65 Million in 2026 to $4457.82 Million in 2034 at a CAGR of 28.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005467
Pages: 230 Pages

AI in Drug Repurposing Market Size, Share and Growth Outlook, 2026: Analysis By Core Platform Type (AI-Based Drug Discovery & Screening Platforms, Knowledge Graphs & Network Biology Tools, AI Algorithms for Target , Predictive Models for Drug Efficacy & Toxicity, AI Tools for Clinical Trial Optimization), By Core Technology (Machine Learning , Deep Learning , Natural Language Processing ), By Search Architecture Strategy (Drug-Centric Repurposing, Disease-Centric Repurposing, Target-Centric Repurposing), By Therapeutic Application Area (Oncology, Neurological & Neurodegenerative Diseases, Infectious Diseases, Cardiovascular Diseases, Metabolic & Autoimmune Disorders, Rare Diseases), By End-User (Pharmaceutical & Large Biopharma Companies, Biotechnology Startups, Contract Research Organizations , Academic, Government, & Private Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global AI in Drug Repurposing Market size is forecast to increase from $1.94 Billion in 2026 to $9.27 Billion in 2034 at a CAGR of 21.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005466
Pages: 227 Pages

AI in Drug Discovery Market Size, Share and Growth Outlook, 2026: Analysis By Component (Software Platforms, Discovery and Development Services), By Technology (Machine Learning (ML) & Deep Learning (DL), Natural Language Processing (NLP), Computer Vision, Quantum Computing), By Stage (Target Identification and Validation, Hit Generation and Prioritization, Lead Optimization, Candidate Screening & Pre-clinical Testing, Drug Repurposing), By Drug (Small Molecules, Biologics, Cell and Gene Therapies), By Therapeutic Area (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global AI in Drug Discovery Market size is forecast to increase from $3.03 Billion in 2026 to $19.87 Billion in 2034 at a CAGR of 26.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005465
Pages: 218 Pages

AI In Clinical Workflow Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Software , Services ), By Technology (Natural Language Processing , Machine Learning & Deep Learning, Computer Vision & Imaging AI, Predictive Analytics), By Function (Clinical Documentation & Information Capture, Patient Intake & Registration, Appointment Scheduling & Management, Diagnostics & Result Interpretation, Care Coordination & Task Management), By Integration Type (Integrated Platforms, Standalone Software), By End User (Inpatient Facilities , Outpatient Facilities , Healthcare IT Vendors) Companies, and Country Forecast, 2021 to 2034

Global AI In Clinical Workflow Market size is forecast to increase from $4.15 Billion in 2026 to $39.19 Billion in 2034 at a CAGR of 32.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005464
Pages: 213 Pages

AI in Clinical Trials Market Size, Share and Growth Outlook, 2026: Analysis By Component (Software/Platforms, Services), By Phase (Phase I, Phase II, Phase III, Phase IV / Post-Marketing Surveillance), By Application (Trial Design & Protocol Optimization, Patient Recruitment & Retention, Site Selection & Monitoring, Data Management & Analytics, Pharmacovigilance & Safety Signal Detection), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Metabolic Disorders), By End User (Pharmaceutical & Biotech Companies, Contract Research Organizations , Medical Device Manufacturers, Academic & Research Centers) Companies, and Country Forecast, 2021 to 2034

Global AI in Clinical Trials Market size is forecast to increase from $1.98 Billion in 2026 to $5.34 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005463
Pages: 225 Pages

AI In Cardiology Market Size, Share and Growth Outlook, 2026: Analysis By Component (Software , Hardware , Services ), By Application (Diagnosis , Prediction & Risk Stratification , Drug Discovery & Biomarker Identification, Remote Patient Monitoring & Telecardiology), By Medical Condition (Ischemic Heart Disease / Coronary Artery Disease , Cardiac Arrhythmias , Heart Failure & Structural Heart Defects, Valvular Heart Diseases), By End-User (Hospitals & Coronary Care Units , Diagnostic & Cardiac Imaging Centers, Specialized Catheterization Laboratories , Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global AI In Cardiology Market size is forecast to increase from $2.46 Billion in 2026 to $18.4 Billion in 2034 at a CAGR of 28.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005462
Pages: 215 Pages

AI In Cancer Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Component (Software Solutions , Hardware , Services ), By Modality (Imaging Diagnostics , Digital Pathology AI , Genomics & Biomarker Discovery, Liquid Biopsies & Molecular Testing), By Application (Screening Support & Early Detection, Triage & Case Prioritization, Tumor Staging & Segmentation Support, Quantification & Biomarker Scoring, Clinical Decision Support & Treatment Selection), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Hematologic Malignancies, Gynecologic Cancers), By End-User (Diagnostic Laboratories & Reference Labs, Hospitals & Specialty Oncology Centers, Biopharmaceutical Companies & Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global AI In Cancer Diagnostics Market size is forecast to increase from $409.88 Million in 2026 to $1637.24 Million in 2034 at a CAGR of 18.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005461
Pages: 225 Pages

AI in Blood Pressure Monitoring Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Wearable Devices , Non-Wearable/Digital Monitors, Cuffless Monitoring Systems), By Technology (Machine Learning Algorithms , Trinity Crown, Deep Learning , Natural Language Processing , Computer Vision ), By Delivery Mode (On-Device AI , Cloud-Based AI, Hybrid AI), By Application (Hypertension Management, Cardiovascular Disease Prediction, Remote Patient Monitoring , Point-of-Care Diagnostics), By End User (Home Healthcare, Hospitals & Specialty Clinics, Ambulatory Surgical Centers , Elderly Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global AI in Blood Pressure Monitoring Market size is forecast to increase from $1.48 Billion in 2026 to $8.88 Billion in 2034 at a CAGR of 25.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005460
Pages: 229 Pages

AI in Biotechnology Market Size, Share and Growth Outlook, 2026: Analysis By Component (Software , Hardware , Services ), By Technology (Machine Learning & Deep Learning, Natural Language Processing , Computer Vision, Generative AI), By Application (Drug Discovery & Development , Precision Medicine, Genomics & Proteomics, Agriculture & Bio-manufacturing, Diagnostics & Medical Imaging), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations , Academic & Research Institutes, Healthcare Providers) Companies, and Country Forecast, 2021 to 2034

Global AI in Biotechnology Market size is forecast to increase from $4.53 Billion in 2026 to $15.27 Billion in 2034 at a CAGR of 16.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005459
Pages: 218 Pages

AI In Animal Health Market Size, Share and Growth Outlook, 2026: Analysis By Component (Hardware , Software , Services ), By Application (Diagnostics & Pathology , Identification, Tracking & Behavior Monitoring, Predictive Health Analytics & Disease Forecasting, Veterinary Practice Management & Telehealth), By Animal Type (Companion Animals , Production / Livestock Animals ), By End-User (Veterinary Hospitals & Referral Centers, Private Veterinary Clinics, Commercial Farms & Livestock Producers, Academic & Research Institutions) Companies, and Country Forecast, 2021 to 2034

Global AI In Animal Health Market size is forecast to increase from $2.6 Billion in 2026 to $8.82 Billion in 2034 at a CAGR of 16.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005458
Pages: 216 Pages